MediWound (MDWD) Net Cash Flow (2013 - 2026)
MediWound (MDWD) posted quarterly Net Cash Flow of -$28.0 million for Q4 2025, down 1145.52% year-over-year from $2.7 million in Q4 2024, and down 188.42% quarter-over-quarter from $31.7 million in Q3 2025.
MediWound (MDWD) Net Cash Flow (2013 - 2026) Analysis & Trends
MediWound's Net Cash Flow history runs 13 years deep, the most recent figure standing at -$28.0 million for Q4 2025.
- In Q4 2025, Net Cash Flow fell 1145.52% year-over-year to -$28.0 million; the TTM figure through Dec 2025 stood at -$4.5 million (down 69.43% YoY), while the FY2025 annual figure was -$4.5 million, down 69.43% from the prior year.
- Net Cash Flow for Q4 2025 stood at -$28.0 million, down from $31.7 million in the prior quarter.
- The five-year high for Net Cash Flow was $31.7 million in Q3 2025, with the low at -$31.7 million in Q2 2023.
- The 5-year median for Net Cash Flow is -$1.0 million (2021), against an average of -$1.6 million.
- The sharpest annual moves came in 2021 and 2025: Net Cash Flow surged 1095.26% in 2021, then slumped 1145.52% in 2025.
- MediWound's Net Cash Flow stood at -$2.5 million in 2021, then jumped by 129.67% to $750000.0 in 2022, then jumped by 194.53% to $2.2 million in 2023, then increased by 21.23% to $2.7 million in 2024, then plunged by 1145.52% to -$28.0 million in 2025.
- Business Quant data shows MDWD's Net Cash Flow at -$28.0 million in Q4 2025, $31.7 million in Q3 2025, and -$302000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | MediWound | 170.65 Mn | 139.65 Mn | 337,000.00 | -11.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.12 Mn |
| Jun 30, 2026 | -11.12 Mn |
| Dec 31, 2025 | -28.00 Mn |
| Dec 31, 2025 | -28.00 Mn |
| Sep 30, 2025 | 31.67 Mn |
| Sep 30, 2025 | 31.67 Mn |
| Jun 30, 2025 | -302,000.00 |
| Jun 30, 2025 | -302,000.00 |
| Mar 31, 2025 | -7.82 Mn |
| Mar 31, 2025 | -7.82 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Dec 31, 2024 | 2.68 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Sep 30, 2024 | 2.67 Mn |
| Jun 30, 2024 | -881,000.00 |
| Jun 30, 2024 | -881,000.00 |
| Mar 31, 2024 | -7.09 Mn |
| Mar 31, 2024 | -7.09 Mn |
| Dec 31, 2023 | 2.21 Mn |
| Dec 31, 2023 | 2.21 Mn |